Last $1.99 USD
Change Today 0.00 / 0.00%
Volume 0.0
CASM On Other Exchanges
As of 8:10 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

cas medical systems inc (CASM) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/28/14 - $2.50
52 Week Low
10/4/13 - $1.21
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CAS MEDICAL SYSTEMS INC (CASM)

Related News

No related news articles were found.

cas medical systems inc (CASM) Related Businessweek News

No Related Businessweek News Found

cas medical systems inc (CASM) Details

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets medical devices for non-invasive patient monitoring in the United States and internationally. The company provides FORE-SIGHT and FORE-SIGHT ELITE absolute tissue oximeter, a cerebral oximeter that offers noninvasive quantitative measurement of cerebral tissue oxygen levels enabling clinicians to identify and quickly react to dangerously low brain oxygen levels, as well as to monitor the oxygenation of other tissues, such as muscle and abdominal tissues in newborns. It also offers bedside vital signs monitors and accessories incorporating various combinations of measurement parameters for human and veterinary use, such as MAXNIBP and MAXIQ non-invasive blood pressure, pulse oximetry, electrocardiography (ECG), temperature, and capnography; and supplies and services, including neonatal intensive care vital signs supplies, such as electrodes and skin temperature probes, as well as various repair services. The company markets its products through its own sales force, manufacturers’ representatives, and original equipment manufacturers, as well as through hospital, surgery center and outpatient facility, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

96 Employees
Last Reported Date: 03/19/14
Founded in 1984

cas medical systems inc (CASM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $311.9K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $216.3K
Vice President of Research & Development
Total Annual Compensation: $189.4K
Compensation as of Fiscal Year 2013.

cas medical systems inc (CASM) Key Developments

CAS Medical Systems to Pay $275,000 to Settle Litigation with Nellcor Puritan Bennett, LLC

CAS Medical Systems announced that it has reached a settlement with Nellcor Puritan Bennett, LLC. Nellcor had filed an action against CASM on Dec. 29, 2011 in the U.S. District Court for the Eastern District of Michigan alleging breach of the settlement agreement with respect to a prior litigation matter between the parties, violation of the Lanham Act, common law unfair competition, and trade libel. Under the settlement, CASM pay $275,000 to Nellcor and give up its claims against Nellcor for legal fees, in exchange for an agreement by Nellcor to dismiss the litigation with prejudice and to provide CASM with certain covenants not to sue with respect to certain comparative advertising matters.

CAS Medical Systems, Inc. Secures $10 Million Loan Agreement with GE Capital Healthcare Financial Services

CAS Medical Systems Inc. announced the company entered into a loan and security agreement with General Electric Capital Corporation. GECC is providing the company with a secured term loan of $7.5 million and a revolving line of credit up to $2.5 million. The term loan and the revolver each mature on June 27, 2018. The term loan requires monthly principal repayments over 36 months commencing July 1, 2015, or over 30 months commencing January 1, 2016, if the company reaches certain financial targets. The company's secured term loan of $5 million with East West Bank was repaid in full at the closing of the Loan Agreement, and the revolving line-of-credit with East West Bank, which had no outstanding balance, was terminated.

CAS Medical Systems Inc. Receives Regulatory Clearance to Market FORE-SIGHT ELITE Oximeters in Japan

CAS Medical Systems Inc. announced receipt of regulatory clearance to market the company's FORE-SIGHT ELITE Cerebral Oximeters in Japan. Under a previously announced exclusive distribution agreement for Japan with Century Medical Inc., CASMED will soon begin shipping FORE-SIGHT ELITE oximetry products to CMI and expects that CMI will begin making the product available to customers in July.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CASM:US $1.99 USD 0.00

CASM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Covidien PLC $91.37 USD +0.37
Hutchinson Technology Inc $2.18 USD +0.12
Masimo Corp $24.49 USD +0.16
Mindray Medical International Ltd $31.02 USD +0.42
Omron Corp ¥4,215 JPY -30.00
View Industry Companies

Industry Analysis


Industry Average

Valuation CASM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAS MEDICAL SYSTEMS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at